The Pharmaceutical Researchand Manufacturers of America, the drug industry trade group, issued a statement saying it approved of most of the major changes.
John Lechleiter, chairman of the trade group Pharmaceutical Researchand Manufacturers of Americaand CEO of Lilly, said Monday that the new program will supplement Interpol's existing efforts.